June 06, 2011

ZALTRAP™ (aflibercept) Significantly Improved Survival in Previously Treated Metastatic Colorectal Cancer Patients

- Results from Pivotal Phase III VELOUR Trial to be Presented at the ESMO World Congress on Gastrointestinal Cancer -

 

ZALTRAP™ (aflibercept) Significantly Improved Survival in Previously Treated Metastatic Colorectal Cancer Patients
- Results from Pivotal Phase III VELOUR Trial to be Presented at the ESMO World Congress on Gastrointestinal Cancer -

Content